FindTrial
Sign In

To assess repigmentation in patients with vitiligo using AVARI (Automated Vitiligo area Repigmentation Index)

An Observational study on Assessment of improvement by using AVARI (Automated Vitiligo area Repigmentation Index) on Pre and Post treatment Digital images of Vitiligo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036800
Enrollment
34
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Deepti Jaiswal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pre and post treatment images of prospective patients of age group more than 6 years who are willing to give informed consent for using AVARI on the images and being photographed

Exclusion criteria

Exclusion criteria: Patients who refuse to be photographed Patients unwilling to participate in the study

Design outcomes

Primary

MeasureTime frame
The main outcome is to evaluate the efficacy of AVARI in assessing the repigmentation in vitiligo lesionsTimepoint: 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDeepti Jaiswal

Kasturba Medical college

sb.pai@manipal.edu9713709798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026